Daniel Hanley: Clinical Trials

1 trial sponsored by Daniel Hanley, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Daniel Hanley: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation
MIS+Cathflo Activase (drug), Intraoperative stereotactic CT-Guided Endoscopic Surgery - Intracerebral Hemorrhage
Phase 2CompletedDaniel Hanley1412005-08-012015-06-18

Conditions studied

Cerebral Hemorrhage (1)

Interventions

Pharmaceutical Preparations (1)

Countries

Canada (1)  ·  Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Daniel F. Hanley, MD (1)  ·  Mario Zuccarello, MD (1)  ·  Paul Vespa, MD (1)

Results publications

PMID 26243227, PMID 26451031, PMID 27751554, PMID 27758940, PMID 32026447

NIH funding

R01NS046309 (1)